Clinical Study for Patients With Hypertension Associated With Dyslipidemia

• Status: Completed
• Trial end date: 2013-07-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to evaluate the efficacy and safety of DWJ1276

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Daewoong Pharmaceutical Co. LTD.
• Treatments: Olmesartan; Olmesartan Medoxomil; Rosuvastatin Calcium

Criteria

Inclusion Criteria:

• Adult male and female in between ages of 20 and 80 at the time of screening

• Subject who can understand information provided and who can sign written consent voluntarily

Exclusion Criteria:

• Patients with hypersensitivity to olmesartan and rosuvastatin

• Pregnant or lactating women and fertile women who is not using proper contraceptive method

• Patient with history of drug or alcohol abuse